13,632 Shares in Henry Schein, Inc. (NASDAQ:HSIC) Bought by Proficio Capital Partners LLC

Proficio Capital Partners LLC bought a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 13,632 shares of the company's stock, valued at approximately $943,000.

Several other institutional investors and hedge funds have also recently modified their holdings of HSIC. Versant Capital Management Inc boosted its stake in Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $32,000 after buying an additional 335 shares during the period. Venturi Wealth Management LLC grew its holdings in Henry Schein by 3,347.1% during the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after acquiring an additional 569 shares in the last quarter. Quent Capital LLC boosted its holdings in Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after purchasing an additional 323 shares in the last quarter. City State Bank purchased a new position in shares of Henry Schein in the 4th quarter valued at $55,000. Finally, Farther Finance Advisors LLC boosted its position in shares of Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock valued at $68,000 after purchasing an additional 346 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Stock Down 3.4 %

Shares of NASDAQ HSIC traded down $2.53 during trading hours on Tuesday, hitting $72.92. The stock had a trading volume of 1,844,686 shares, compared to its average volume of 2,053,710. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a market capitalization of $9.05 billion, a P/E ratio of 30.01, a P/E/G ratio of 2.13 and a beta of 0.90. The firm's 50-day moving average price is $74.69 and its two-hundred day moving average price is $72.63. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49.

Remove Ads

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.66 earnings per share. Analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on HSIC shares. Jefferies Financial Group increased their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Barrington Research reissued an "outperform" rating and set a $90.00 price objective on shares of Henry Schein in a report on Wednesday, February 26th. UBS Group lowered their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and boosted their price target for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Finally, Wells Fargo & Company began coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price on the stock. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $81.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.